From the results of large-scale genomic analyses, it has become clear that gene mutations in HCC are centered on diverse non-drug targetable mutations, such as TERT, CTNNB1, and TP53 [50,51]. This evidence concerns the gene CTNNB1 and hepatocellular carcinoma.